Food and Drug Administration

FDA’s Week of Innovation: Scallops Alert, AI Health Challenge Winners, Digital Health Equity & Novel Drug Approvals

WASHINGTON, D.C. — In a series of announcements last week, the U.S. Food and Drug Administration (FDA) showcased its broad range of responsibilities, from food safety to advancing medical technology …

FDA’s Week of Innovation: Scallops Alert, AI Health Challenge Winners, Digital Health Equity & Novel Drug Approvals Read More
Neuraptive Therapeutics

Neuraptive Therapeutics’ Groundbreaking Study Paves Way for Improved Peripheral Nerve Injury Treatment

WAYNE, PA — Neuraptive Therapeutics, Inc., a Pennsylvania-based biotech company, recently announced a major breakthrough in the treatment of peripheral nerve injuries. The firm’s successful demonstration of proof-of-concept in the …

Neuraptive Therapeutics’ Groundbreaking Study Paves Way for Improved Peripheral Nerve Injury Treatment Read More

School Safety

Pennsylvania Schools to Receive $155M Boost for Safety and Security, with Emphasis on Mental Health Resources

HARRISBURG, PA — Pennsylvania schools are set to benefit from a substantial investment in safety and security measures, including a significant focus on mental health resources. The Pennsylvania Commission on …

Pennsylvania Schools to Receive $155M Boost for Safety and Security, with Emphasis on Mental Health Resources Read More

Aclaris Therapeutics

Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has released promising top-line results from its Phase 2b study of ATI-1777, a topical “soft” JAK 1/3 inhibitor developed for treating mild …

Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence Read More

Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Achieves Milestone in Phase 2 Trial of Groundbreaking Skin Cancer Therapy

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leader in dermatology therapeutics, announced a significant development in its ongoing research for innovative skin cancer treatments. The company confirmed …

Verrica Pharmaceuticals Achieves Milestone in Phase 2 Trial of Groundbreaking Skin Cancer Therapy Read More